As a potential treatment of COVID-19: Montelukast

Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/41712

Título :	As a potential treatment of COVID-19: Montelukast
Autor:	Fidan, Cihan Aydoğdu, Ayşe
Publicador:	Elsevier
Data da publicação:	Set-2020
Referência:	FIDAN, C.; AYDOĞDU, A. As a potential treatment of COVID-19: Montelukast. Medical Hypotheses, [S.l.], v. 142, Sept. 2020.
Abstract:	It has been hypothesized that Montelukast, a cysteinyl leukotriene (cysLT) receptor antagonist, with effects of anti-inflammatory, suppress oxidative stress and reduce affect cytokine production, may limited progression of the disease on COVID-19 infection.
URI:	https://www.sciencedirect.com/science/article/pii/S0306987720306368 http://repositorio.ufla.br/jspui/handle/1/41712
Idioma:	en_US
Aparece nas coleções:	FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:

Não existem arquivos associados a este item.